Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia

Neuroscience

Volumn 86, Issue 2, 1998, Pages 437-448

  Eastwood, S L ^a   Harrison, P J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Cerebral cortex; GAP 43; Hippocampus; Human brain; mRNA; Plasticity

Indexed keywords

MESSENGER RNA; NEUROMODULIN; SYNAPTOPHYSIN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA; SYNAPSE; TEMPORAL LOBE; VISUAL CORTEX;

ADULT; AGED; CEREBRAL CORTEX; FEMALE; GAP-43 PROTEIN; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; ORGAN SPECIFICITY; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; TRANSCRIPTION, GENETIC; VISUAL CORTEX;

EID: 0032101622     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00040-2     Document Type: Article

References (69)

1. American Psychiatric Association (1991) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC.
2. Arnold S. E., Trojanowski J. Q. Recent advances in defining the neuropathology of schizophrenia. Acta neuropath. 92:1996;217-231.
3. Barbeau D., Liang J. J., Robitaille Y., Quirion R., Srivasta L. K. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc. natn. Acad. Sci. U.S.A. 92:1995;2785-2789.
4. Barton A. J. L., Pearson R. C. A., Najlerahim A., Harrison P. J. Pre- and post-mortem influences on brain RNA. J. Neurochem. 61:1993;1-11.
5. Bendotti C., Pende M., Samanin R. Expression of GAP-43 in the granule cells of the rat hippocampus after seizure-induced sprouting of mossy fibres: in situ hybridization and immunocytochemical studies. Eur. J. Neurosci. 6:1994;509-515.
6. Benes F. M. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr. Bull. 19:1993;537-549.
7. Benes F. M., Turtle M., Khan Y., Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Archs gen. Psychiat. 51:1994;477-484.
8. Benowitz L. I., Routtenberg A. A membrane phosphoprotein associated with neural development, axonal regeneration, phospholipid metabolism and synaptic plasticity. Trends Neurosci. 10:1987;527-532.
9. Benowitz L. I., Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20:1997;84-91.
10. Benowitz L. I., Perrone-Bizzozero N., Finklestein S., Bird E. D. Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex. J. Neurosci. 9:1989;990-995.
11. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology. 15:1996;442-455.
12. Callahan L. M., Selski D. J., Martzen M. R., Cheetham J. E., Coleman P. D. Preliminary evidence of decreased GAP-43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus. Neurobiol. Aging. 15:1994;381-386.
13. Chao H. M., McEwen B. S. Glucocorticoids and the expression of mRNAs for neurotrophins, their receptors and GAP-43 in the rat hippocampus. Molec. Brain Res. 26:1994;271-276.
14. Chomczynski P., Sacchi N. A single step method for the isolation of RNA using the acid-phenol-chloroform method. Analyt. Biochem. 162:1987;156-159.
15. Coleman P. D., Kazee A. M., Lapham L., Eskin T., Rogers K. Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease. Neurobiol. Aging. 13:1992;631-639.
16. de la Monte S. M., Federoff H. J., Ng S.-C., Grabczyk E., Fishman M. C. GAP-43 gene expression during development: persistence in a distinctive set of neurons in the mature central nervous system. Devl Brain Res. 46:1989;161-168.
17. de la Monte S. M., Ng S.-C., Hsu D. Aberrant GAP-43 expression in Alzheimer's disease. Am. J. Path. 147:1995;934-946.
18. DeLisi L. E. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr. Bull. 23:1997;119-129.
19. Doster S. K., Lozano A. M., Agauyo A. J., Willard M. B. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron. 6:1991;635-647.
20. Eastwood S. L., Harrison P. J. Decreased synaptophysin in the medial temporal lobe in schizophrenia using immunoautoradiography. Neuroscience. 69:1995;339-343.
21. Eastwood S. L., Burnet P. W. J., Harrison P. J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 66:1995;309-319.
22. Eastwood S. L., Heffernan J., Harrison P. J. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Molec. Psychiat. 2:1997;322-329.
23. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. psychiat. Res. 17:1982;319-330.
24. Fields R. D., Itoh K. Neural cell adhesion molecules in activity-dependent development and synaptic plasticity. Trends Neurosci. 19:1996;473-480.
25. Gabriel S. M., Haroutunian V., Powchik P., Honer W. G., Davidson M., Davies P., Davis K. L. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Archs gen. Psychiat. 54:1997;559-566.
26. Gispen W. H., Nielander H. B., DeGraan P. N., Oestreicher A., Schrama L., Schotman P. Role of the growth-associated protein B-50/GAP-43 in neuronal plasticity. Molec. Neurobiol. 5:1992;61-65.
27. Glantz L. A., Lewis D. A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Archs gen. Psychiat. 54:1997;660-669.
28. Goldman-Rakic P. S., Selemon L. D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23:1997;437-458.
29. Haracz J. L. Neural plasticity in schizophrenia. Schizophr. Bull. 11:1985;191-229.
30. Harrison P. J. Schizophrenia: a disorder of neurodevelopment? Curr. Opin. Neurobiol. 7:1997;285-289.
31. Harrison P. J. (1997b) Schizophrenia and its dementia. In The Neuropathology of Dementia (eds Esiri M. M. and Morris J. H.), pp. 383-395. Cambridge University Press, Cambridge.
32. Harrison P. J., Heath P. R., Eastwood S. L., Burnet P. W. J., McDonald B., Pearson R. C. A. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with the encoded proteins. Neurosci. Lett. 200:1995;151-154.
33. Harrison P. J., Burnet P. W. J., Falkai P., Bogerts B., Eastwood S. L. Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in hippocampal formation and cerebral cortex. Schizophr. Res. 26:1997;93-102.
34. Honer W. G., Falkai P., Young C., Wang T., Xie J., Bonner J., Hu L., Boulianne G. L., Luo Z., Trimble W. S. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience. 78:1997;99-110.
35. Jeffery K. J., Reid I. C. Modifiable neuronal connections: an overview for psychiatrists. Am. J. Psychiat. 154:1997;156-164.
36. Kanazir S., Ruzdijic S., Vukosavic S., Ivkovic S., Milosevic A., Zecevic N., Rakic L. GAP-43 mRNA expression in early development of human nervous system. Molec. Brain Res. 38:1996;145-155.
37. Karns L. R., Ng S.-C., Freeman J. A., Fishman M. C. Cloning of the complementary DNA for GAP-43, a neuronal growth-related protein. Science. 236:1987;597-600.
38. Keshavan M. S., Anderson S., Pettegrew J. W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. psychiat. Res. 28:1994;239-265.
39. Kingsbury A. E., Foster O. J. F., Nisbet A. P., Cairns N., Bray L., Eve D. J., Lees A. J., Marsden C. D. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Molec. Brain Res. 28:1995;311-318.
40. Kosik K., Orecchio L., Burns G., Benowitz L. I., MacDonald G. P., Cox D. R., Neve R. L. Human GAP-43: its deduced amino acid sequence and chromosomal localization in mouse and human. Neuron. 1:1988;127-132.
41. Kruger L., Bendotti C., Rivolta R., Samanin R. Distribution of GAP-43 mRNA in the adult rat brain. J. comp. Neurol. 333:1993;417-434.
42. Levin B. E., Dunn-Meyell A. Regulation of growth-associated protein-43 (GAP-43) messenger RNA associated with plastic change in the adult rat barrel receptor complex. Molec. Brain Res. 18:1993;59-70.
43. Liddle P. F. Functional imaging - schizophrenia. Br. med. Bull. 52:1996;486-494.
44. Lin L.-H., Bock S., Carpenter K., Rose M., Norden J. J. Synthesis and transport of GAP-43 in entorhinal cortex neurons and perforant pathway during lesion-induced sprouting and reactive synaptogenesis. Molec. Brain Res. 14:1992;147-153.
45. Liu Y., Meiri K. F., Cynader M. S., Gu Q. Nerve growth factor induced modification of presynaptic elements in adult visual cortex in vivo. Brain Res. 732:1996;36-42.
46. Masliah E., Fagan A. M., Terry R. D., DeTeresa R., Mallory M., Gage F. H. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Expl Neurol. 113:1991;131-142.
47. McGuire P. K., Frith C. D. Disordered functional connectivity in schizophrenia. Psychol. Med. 26:1996;663-667.
48. Meberg P. J., Routtenberg A. Selective expression of protein F1/(GAP-43) mRNA in pyramidal but not granule cells of the hippocampus. Neuroscience. 45:1991;721-733.
49. Miller M., Urban J. and Dorsa D. (1989) Quantification of mRNA in discrete cell groups of brain by in situ hybridization histochemistry. In Methods in Neuroscience (ed. Conn P. M.), Vol. 1, pp. 164-181. Academic, San Diego.
50. Neve R. L., Bear M. F. Visual experience regulates gene expression in the developing striate cortex. Proc. natn. Acad. Sci. U.S.A. 86:1989;4781-4784.
51. Neve R. L., Perrone-Bizzozero N. I., Finklestein S., Zwiers H., Bird E., Kurnit D. M., Benowitz L. I. The neuronal growth-associated protein GAP-43 (B-50, F1): neuronal specificity, developmental regulation and regional distribution of the human and rat mRNAs. Molec. Brain Res. 2:1987;177-183.
52. Neve R. L., Finch E. A., Bird E. D., Benowitz L. I. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. natn. Acad. Sci. U.S.A. 85:1988;3638-3642.
53. Ng S.-C., de la Monte S. M., Conboy G. L., Karns L. R., Fishman M. C. Cloning of human GAP-43: growth association and ischemic resurgence. Neuron. 1:1988;133-139.
54. Palacios G., Mengod G., Savasa M., Baudier J., Palacios J. M. De novo synthesis of GAP-43: in situ hybridization histochemistry and light and electron microscopy immunocytochemical studies in regenerating neurons of cranial nerve nuclei in the rat brain. Molec. Brain Res. 24:1994;107-117.
55. Parhad I. M., Oishi R., Clark A. M. GAP-43 gene expression is increased in anterior horn cells of amyotrophic lateral sclerosis. Ann. Neurol. 31:1992;593-597.
56. Pearlson G. D., Petty R. G., Ross C. A., Tien A. Y. Schizophrenia: a disease of heteromodal association cortex. Neuropsychopharmacology. 14:1996;1-17.
57. Perrone-Bizzozero N. I., Sower A. C., Bird E. D., Benowitz L. I., Ivins K. J., Neve R. L. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc. natn. Acad. Sci. U.S.A. 93:1996;14182-14187.
58. Port R. L., Seybold K. S. Hippocampal synaptic plasticity as a biological substrate underlying episodic psychosis. Biol. Psychiat. 37:1995;318-324.
59. Selemon L. D., Rajkowska G., Goldman-Rakic P. S. Abnormally high neuronal density in the schizophrenic cortex - a morphometric analysis of prefrontal area 9 and occipital area 17. Archs gen. Psychiat. 52:1995;805-818.
60. Skene J. H. P. Axonal growth-associated proteins. A. Rev. Neurosci. 12:1989;127-156.
61. Sower A. C., Bird E. D., Perrone-Bizzozero N. I. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method. Molec. chem. Neuropath. 24:1995;1-11.
62. Stevens J. Abnormal reinnervation as a basis for schizophrenia. A hypothesis. Archs gen. Psychiat. 49:1992;238-243.
63. Tsai K.-C., Cansino V. V., Kohn D. T., Neve R. L., Perrone-Bizzozero N. I. Post-transcriptional regulation of the GAP-43 gene by specific sequences in the 3′ untranslated region of the mRNA. J. Neurosci. 17:1996;1950-1958.
64. Waddington J. Schizophrenia: developmental neuroscience and pathobiology. Lancet. 341:1993;531-536.
65. Webster M. J., Shannon-Weickert C., Herman M. M., Hyde T. M., Kleinman J. E. Localization of GAP-43 and BDNF mRNA in the human visual cortex during postnatal development. Soc. Neurosci. Abstr. 23:1997;81.
66. Weinberger D. R. Schizophrenia: from neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
67. Woodruff P. W. R., Wright I. C., Shurique N., Russow H., Rushe T., Howard R. J., Graves M., Bullmore E. T., Murray R. M. Structural brain abnormalities in male schizophrenics reflect fronto-temporal dissociation. Psychol. Med. 27:1997;1257-1266.
68. Yao G. L., Kiyama H., Tohyama M. Distribution of GAP-43 (B50/F1) mRNA in the adult rat brain by in situ hybridization using an alkaline phosphatase labelled probe. Molec. Brain Res. 18:1993;1-16.
69. Zaidel D. W., Esiri M. M., Harrison P. J. The hippocampus in schizophrenia: lateralized increases in neuronal density and altered cytoarchitectural asymmetry. Psychol. Med. 27:1997;703-711.